Human immunodeficiency virus evolution towards reduced replicative fitness in vivo and the development of AIDS

被引:26
作者
Wodarz, Dominik
Levy, David N.
机构
[1] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA
[2] NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA
关键词
HIV dynamics; mathematical models; evolution; disease progression; coinfection; fitness;
D O I
10.1098/rspb.2007.0413
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human immunodeficiency virus (HIV) infection progresses to AIDS following an asymptomatic period during which the virus is thought to evolve towards increased fitness and pathogenicity. We show mathematically that progression to the strongest HIV-induced pathology requires evolution of the virus towards reduced replicative fitness in vivo. This counter-intuitive outcome can happen if multiple viruses co-infect the same cell frequently, which has been shown to occur in recent experiments. According to our model, in the absence of frequent co-infection, the less fit AIDS-inducing strains might never emerge. The frequency of co-infection can correlate with virus load, which in turn is determined by immune responses. Thus, at the beginning of infection when immunity is strong and virus load is low, co-infection is rare and pathogenic virus variants with reduced replicative fitness go extinct. At later stages of infection when immunity is less efficient and virus load is higher, co-infection occurs more frequently and pathogenic virus variants with reduced replicative fitness can emerge, resulting in T-cell depletion. In support of these notions, recent data indicate that pathogenic simian immunodeficiency virus (SIV) strains occurring late in the infection are less fit in specific in vitro experiments than those isolated at earlier stages. If co-infection is blocked, the model predicts the absence of any disease even if virus loads are high. We hypothesize that non-pathogenic SIV infection within its natural hosts, which is characterized by the absence of disease even in the presence of high virus loads, could be explained by a reduced occurrence of co-infection in this system.
引用
收藏
页码:2481 / 2490
页数:10
相关论文
共 50 条
  • [41] Development and Assessment of a Multiplex Real-Time PCR Assay for Quantification of Human Immunodeficiency Virus Type 1 DNA
    Beloukas, A.
    Paraskevis, D.
    Haida, C.
    Sypsa, V.
    Hatzakis, A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) : 2194 - 2199
  • [42] Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?
    Gudo, Eduardo Samo
    Bhatt, Nilesh B.
    Bila, Dulce Ramalho
    Abreu, Celina Monteiro
    Tanuri, Amilcar
    Savino, Wilson
    Silva-Barbosa, Suse Dayse
    Jani, Ilesh V.
    BMC INFECTIOUS DISEASES, 2009, 9
  • [43] Role of Regulatory T Cells and Inhibitory Molecules in the Development of Immune Exhaustion During Human Immunodeficiency Virus Type 1 Infection
    Milena Gonzalez, Sandra
    Zapata, Wildeman
    Teresa Rugeles, Maria
    VIRAL IMMUNOLOGY, 2016, 29 (01) : 2 - 10
  • [44] Contribution of Human Immunodeficiency Virus Type 1 Minority Variants to Reduced Drug Susceptibility in Patients on an Integrase Strand Transfer Inhibitor-Based Therapy
    Gibson, Richard M.
    Weber, Jan
    Winner, Dane
    Miller, Michael D.
    Quinones-Mateu, Miguel E.
    PLOS ONE, 2014, 9 (08):
  • [45] Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis
    Biru, T.
    Lennemann, T.
    Stuermer, M.
    Stephan, C.
    Nisius, G.
    Cinatl, J.
    Staszewski, S.
    Guertler, L. G.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2010, 199 (04) : 323 - 332
  • [46] Drug-associated changes in amino acid residues in Gag p2, p7NC, and p6Gag/p6Pol in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response
    Ho, Sarah K.
    Coman, Roxana M.
    Bunger, Joshua C.
    Rose, Stephanie L.
    O'Brien, Patricia
    Munoz, Isabel
    Dunn, Ben M.
    Sleasman, John W.
    Goodenow, Maureen M.
    VIROLOGY, 2008, 378 (02) : 272 - 281
  • [47] Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China
    Jianjian Li
    Yawen Xu
    Jiafa Liu
    Bihui Yang
    Cuixian Yang
    Mi Zhang
    Xingqi Dong
    Virology Journal, 16
  • [48] Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China
    Li, Jianjian
    Xu, Yawen
    Liu, Jiafa
    Yang, Bihui
    Yang, Cuixian
    Zhang, Mi
    Dong, Xingqi
    VIROLOGY JOURNAL, 2019, 16 (1)
  • [49] Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G
    Konings, FAJ
    Burda, ST
    Urbanski, MM
    Zhong, P
    Nadas, A
    Nyambi, PN
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (05) : 523 - 534
  • [50] Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment
    Li, Luna
    Aiamkitsumrit, Benjamas
    Pirrone, Vanessa
    Nonnemacher, Michael R.
    Wojno, Adam
    Passic, Shendra
    Flaig, Katherine
    Kilareski, Evelyn
    Blakey, Brandon
    Ku, Jade
    Parikh, Nirzari
    Shah, Rushabh
    Martin-Garcia, Julio
    Moldover, Brian
    Servance, Laila
    Downie, David
    Lewis, Sharon
    Jacobson, Jeffrey M.
    Kolson, Dennis
    Wigdahl, Brian
    JOURNAL OF NEUROVIROLOGY, 2011, 17 (01) : 92 - 109